Trial Profile
A Randomized, Controlled, Open Label, Phase II Study of Visudyne [verteporfin] Photodynamic Therapy (PDT) Combined With Bevacizumab (Avastin) vs Avastin Alone in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Verteporfin (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- Acronyms ARMAST